TABLE 22. Reported abortions, by known weeks of gestation and method type — selected reporting areas,* United States, 2014.
| Method type | Weeks of gestation |
Total |
|||||
|---|---|---|---|---|---|---|---|
| ≤8 |
9–13 |
14–15 |
16–17 |
18–20 |
≥21 |
||
| No. (%)† | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | |
|
Surgical§
| |||||||
| ≤13 weeks gestation |
177,232 (66.7) |
103,328 (96.8) |
NA |
NA |
NA |
NA |
280,560 (68.5)
|
| >13 weeks gestation |
NA |
NA |
14,431 (98.9) |
9,047 (98.5) |
7,848 (96.8) |
4,845 (90.1) |
36,171 (8.8)
|
|
Medical¶
| |||||||
| ≤8 weeks gestation |
88,604 (33.3) |
NA |
NA |
NA |
NA |
NA |
88,604 (21.6)
|
| >8 weeks gestation |
NA |
3,348 (3.1) |
130 (0.9) |
112 (1.2) |
224 (2.8) |
487 (9.1) |
4,301 (1.0)
|
|
Intrauterine instillation
|
—** |
18 (0.0) |
23 (0.2) |
12 (0.1) |
28 (0.3) |
36 (0.7) |
117 (0.0)
|
|
Hysterectomy/Hysterotomy
|
17 (0.0) |
12 (0.0) |
4 (0.0) |
11 (0.1) |
8 (0.1) |
8 (0.1) |
60 (0.0)
|
| Total | 265,853 (100.0) | 106,706 (100.0) | 14,588 (100.0) | 9,182 (100.0) | 8,108 (100.0) | 5,376 (100.0) | 409,813 (100.0) |
Abbreviation: NA = not applicable.
* Data from 36 reporting areas; excludes 16 areas (California, Connecticut, District of Columbia, Florida, Hawaii, Illinois, Kentucky, Louisiana, Maryland, Massachusetts, New Hampshire, New York State, Pennsylvania, Tennessee, Wisconsin, and Wyoming) that did not report, did not report by method type or gestational age, did not meet reporting standards, or did not have medical abortion as a specific category on their reporting form.
† For each gestational age category, percentages of all method types might not add to 100 because of rounding.
§ Includes aspiration curettage, suction curettage, manual vacuum aspiration, menstrual extraction, sharp curettage, and dilation and evacuation procedures.
¶ The administration of medication or medications to induce an abortion; at ≤8 weeks’ gestation, typically involves the use of mifepristone and misoprostol; at >8 weeks’ gestation, typically involves the use of vaginal prostaglandins.
** Intrauterine instillations reported at ≤12 weeks’ gestation have not been included with known values.